Loupe-Based Intraoperative Fluorescence Imaging

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorGuoqiang Yu

About this trial

Glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) are the most common primary malignant brain tumors. Survival of patients with these brain tumors is directly related to the extent of resection. Consequently, a great deal of effort has been directed at developing techniques and technologies that allow more extensive, safe resections.

This study will test a loupe-based wearable device in the clinical setting and compare its accuracy with a large operative microscope to identify tumor tissues. Postoperative histopathological analysis on tumor tissues will be used as gold standards for comparison. The outcome from this study will be a low-cost, miniaturized, easy-to-operate, loupe-based fluorescence imaging device for intraoperative guidance of brain tumor resection with the same level of accuracy as the large microscope.

Eligibility criteria

Qualifiers

adults with brain malignant gliomas undergoing resection

at least 18 years of age

able to understand the consent

Disqualifiers

pregnant women

under 18 years of age

patients undergoing emergency surgery

inability to give consent due to dysphagia or language barrier

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Guoqiang Yu

Lead sponsor

University of Kentucky

Sponsor institution

Bioptics Technology LLC

Collaborator

National Cancer Institute (NCI)

Collaborator

Kentucky Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)

Collaborator